Literature DB >> 16043738

Ethnicity, race, and baseline retinopathy correlates in the veterans affairs diabetes trial.

Nicholas Emanuele1, Jerome Sacks, Ronald Klein, Domenic Reda, Robert Anderson, William Duckworth, Carlos Abraira.   

Abstract

OBJECTIVE: The Veterans Affairs Diabetes Trial (VADT) cohort is enriched with approximately 20% Hispanics and 20% African Americans, affording a unique opportunity to study ethnic differences in retinopathy. RESEARCH DESIGN AND METHODS: Cross-sectional analyses on the baseline seven-field stereo fundus photos of 1,283 patients are reported here. Diabetic retinopathy scores are grouped into four classes of increasing severity: none (10-14), minimal nonproliferative diabetic retinopathy (NPDR) (15-39), moderate to severe NPDR (40-59), and proliferative diabetic retinopathy (60+). These four groups have also been dichotomized to none or minimal (10-39) and moderate to severe diabetic retinopathy (40+).
RESULTS: The prevalence of diabetic retinopathy scores >40 was higher for Hispanics (36%) and African Americans (29%) than for non-Hispanic whites (22%). The difference between Hispanics and non-Hispanic whites was significant (P < 0.05). Similarly, the prevalence of diabetic retinopathy scores >40 was significantly higher in African Americans than in non-Hispanic whites (P < 0.05). These differences could not be accounted for by an imbalance in traditional risk factors such as age, duration of diagnosed diabetes, HbA(1c) (A1C), and blood pressure. Diabetic retinopathy severity scores were also significantly associated with increasing years of disease duration, A1C, systolic and diastolic blood pressure, the degree of microalbuminuria, fibrinogen, and the percentage of patients with amputations. There was no relationship between retinopathy severity and the percentage of people who had strokes or cardiac revascularization procedures. There was an inverse relationship between retinopathy severity and total cholesterol, triglycerides, and plasminogen activator inhibitor-1 as well as with smoking history. Diabetic retinopathy scores were not associated with age.
CONCLUSIONS: In addition to many well-known associations with retinopathy, a higher frequency of severe diabetic retinopathy was found in the Hispanic and African-American patients at entry into the VADT that is not accounted for by traditional risk factors for diabetic retinopathy, and these substantial ethnic differences remain to be explained.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16043738     DOI: 10.2337/diacare.28.8.1954

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  46 in total

Review 1.  Closing the gap: eliminating health care disparities among Latinos with diabetes using health information technology tools and patient navigators.

Authors:  Lenny López; Richard W Grant
Journal:  J Diabetes Sci Technol       Date:  2012-01-01

2.  The association analysis polymorphism of CDKAL1 and diabetic retinopathy in Chinese Han population.

Authors:  Nai-Jia Liu; Qian Xiong; Hui-Hui Wu; Yan-Liang Li; Zhen Yang; Xiao-Ming Tao; Yan-Ping Du; Bin Lu; Ren-Ming Hu; Xuan-Chun Wang; Jie Wen
Journal:  Int J Ophthalmol       Date:  2016-05-18       Impact factor: 1.779

3.  Blood pressure, antihypertensive medication use, and risk of erectile dysfunction in men with type I diabetes.

Authors:  Aruna V Sarma; James M Hotaling; Ian H de Boer; Rodney L Dunn; Mary K Oerline; Karandeep Singh; Jack Goldberg; Alan Jacobson; Barbara Braffett; William H Herman; Rodica Pop-Busui; Hunter Wessells
Journal:  J Hypertens       Date:  2019-05       Impact factor: 4.844

4.  Diabetic Retinopathy: Focus on Minority Populations.

Authors:  Arpine Barsegian; Boleslav Kotlyar; Justin Lee; Moro O Salifu; Samy I McFarlane
Journal:  Int J Clin Endocrinol Metab       Date:  2017-11-11

5.  Evaluation of a SNP map of 6q24-27 confirms diabetic nephropathy loci and identifies novel associations in type 2 diabetes patients with nephropathy from an African-American population.

Authors:  Tennille S Leak; Josyf C Mychaleckyj; Shelly G Smith; Keith L Keene; Candace J Gordon; Pamela J Hicks; Barry I Freedman; Donald W Bowden; Michèle M Sale
Journal:  Hum Genet       Date:  2008-06-17       Impact factor: 4.132

6.  The albino mutation of tyrosinase alters ocular angiogenic responsiveness.

Authors:  Michael S Rogers; Irit Adini; Aaron F McBride; Amy E Birsner; Robert J D'Amato
Journal:  Angiogenesis       Date:  2013-02-20       Impact factor: 9.596

7.  Risk Factors for Proliferative Diabetic Retinopathy in African Americans with Type 2 Diabetes.

Authors:  Alan Penman; Heather Hancock; Evangelia Papavasileiou; Maurice James; Omolola Idowu; Daniel M Riche; Marlene Fernandez; Stacey Brauner; Sataria O Smith; Suzanne Hoadley; Cole Richardson; Vanessa Vazquez; Cheryl Chi; Christopher Andreoli; Deeba Husain; Ching J Chen; Lucia Sobrin
Journal:  Ophthalmic Epidemiol       Date:  2016-03-07       Impact factor: 1.648

8.  The association of retinopathy and low GFR in type 2 diabetes.

Authors:  A K Mottl; K S Kwon; S Garg; E J Mayer-Davis; R Klein; A V Kshirsagar
Journal:  Diabetes Res Clin Pract       Date:  2012-10-12       Impact factor: 5.602

9.  Identification of Diabetic Retinopathy Genes through a Genome-Wide Association Study among Mexican-Americans from Starr County, Texas.

Authors:  Yi-Ping Fu; D Michael Hallman; Victor H Gonzalez; Barbara E K Klein; Ronald Klein; M Geoffrey Hayes; Nancy J Cox; Graeme I Bell; Craig L Hanis
Journal:  J Ophthalmol       Date:  2010-09-02       Impact factor: 1.909

10.  Higher prevalence of retinopathy in diabetic patients of South Asian ethnicity compared with white Europeans in the community: a cross-sectional study.

Authors:  Neil T Raymond; Lakshminarayanan Varadhan; Dilini R Reynold; Kate Bush; Sailesh Sankaranarayanan; Srikanth Bellary; Anthony H Barnett; Sudhesh Kumar; J Paul O'Hare
Journal:  Diabetes Care       Date:  2008-12-15       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.